
Sign up to save your podcasts
Or


In this third episode we will ask for tips and tricks from senior physician Johanna Syvänen from Turku university hospital, when using BG-S53P4 in benign bone tumor surgery
In this second episode, we will talk about the surgical technique in benign bone tumor surgery. In the article, it stated following "Autograft is the generally preferred material for benign bone lesions needing intralesional curettage and filling. However, large cysts require a substantial amount of bone graft, which might not be available in younger children. Therefore, an optimal bone substitute would be useful."
Our guest today is Head of Pediatric Orthopedic department, Johanna Syvänen from Turku University Hospital. Johanna is a pediatric orthopedic surgeon with over 30 peer-reviewed scientific publications. Today she is here to discuss the recently published clinical paper: Allograft Versus Bioactive Glass (BG-S53P4) in Pediatric Benign Bone Lesions.
From the publisher's feed
Welcome to the Smart Healing™ Podcast, your go-to forum for engaging discussions with surgeons and authors about intriguing scientific papers. We understand that time is a precious commodity and…
Bioactive glass, originally developed by Larry Hench from the United States, has been further developed by scientists in Turku, Finland providing the only formulation of Bioactive glass, S53P4, that inhibits bacterial growth. I’m your host, Tanja Wigell, serving as an International Product Manager at Bonalive Biomaterials. Join me as we delve into the captivating world of S53P4 bioactive glass and its myriad of applications for Smart Healing™.